Search

Your search keyword 'covid' showing total 365,105 results

Search Constraints

Start Over You searched for: covid Remove constraint covid Topic sars-cov-2 Remove constraint Topic: sars-cov-2
365,105 results on 'covid'

Search Results

1. [Long-/Post-COVID symptoms in a hotspot collective of the first wave of the SARS-CoV-2 pandemic in Germany].

2. COVID-19. Impact on Public Health and Healthcare.

3. Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants.

4. Association of obesity status and the risk of long-COVID: Isfahan COVID cohort study.

5. Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis.

6. The effectiveness of telemedicine methods in the follow-up of asthma in the COVID-19 pandemic process.

7. Uncertainty in COVID-19 transmission could undermine our ability to predict long COVID.

8. The Effectiveness of COVID-19 Vaccination on Post-Acute Sequelae of SARS-CoV-2 Infection Among Geriatric Patients.

9. Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS study.

10. Avidity maturation of anti-spike IgG after vaccination in COVID-19 convalescent vs COVID-19 naïve patients.

11. Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study.

12. Inflammatory discoveries two years after acute severe COVID-19: a longitudinal biomarker profile assessment in long COVID individuals in the Brazilian Amazon.

13. Defining long COVID using a population-based SARS-CoV-2 survey in California.

14. COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study.

15. Long COVID and pituitary dysfunctions: a bidirectional relationship?

16. [Analysis of the long-term effects of COVID-19 infection (long-COVID) in Italy during and after the pandemic emergency and response strategy].

17. The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosis.

18. From Viral Infection to Skin Affliction: Unveiling Mechanisms of Cutaneous Manifestations in COVID-19 and Post-COVID Conditions.

19. The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023-2024 phase of JN.1 subvariant dominance.

20. Structural and Functional Glycosylation of the Abdala COVID-19 Vaccine.

21. Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production.

22. Increased Mortality in Kidney Transplant Recipients During the Delta/Omicron Era of the COVID-19 Pandemic Despite Widespread Vaccination.

23. Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID-19 Infection.

24. Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial.

25. Lessons Learned From Clinical Trials of Immunotherapeutics for COVID-19.

26. Intrinsic Factors Behind the Long-COVID: V. Immunometabolic Disorders.

27. Age-structured modeling of COVID-19 dynamics: the role of treatment and vaccination in controlling the pandemic.

28. Hybrid immunity protection against SARS-CoV-2 and severe COVID-19 in kidney transplantation: A retrospective, comparative cohort study.

29. A clinical case study of seven patients of autonomic dysfunction in post COVID-19 conditions with fever as the main clinical symptom: a case series.

30. Post-COVID symptoms after SARS-CoV-2 omicron infection and the effect of booster vaccination: A population-based cohort study.

31. SARS-CoV-2 positivity rates in tear secretions of inpatient COVID-positive individuals in an Indian tertiary care setting.

32. Symptoms of post COVID-19 condition and diseases/conditions diagnosed after COVID-19 in Japanese patients: A real-world study using a claims database.

33. Mental illness and antibody responses after COVID-19 vaccination in a prospective population-based study in Catalonia.

34. Association between long-term exposure to air pollutants with breakthrough SARS-CoV-2 infections and antibody responses among COVID-19 vaccinated older adults in Northern Italy.

35. Clinical Characteristics During and After COVID-19 Infection Among Healthcare Workers During the First Wave of Omicron in Chongqing, China.

36. Thyroid Hormones Determination in Euthyroid and LT4-Treated Patients During COVID-19 Hospitalization.

37. Therapeutic BCG vaccine protects against long COVID: The BATTLE randomized clinical trial.

38. Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study.

39. SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.

40. Long COVID among the first three waves of COVID-19 in Japan: a multicentre cohort study.

41. Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19.

42. Development of a prediction nomogram for IgG levels among asymptomatic or mild patients with COVID-19.

43. Access to and utilisation of COVID-19 antigen rapid diagnostic tests (Ag-RDTs) among the general population in Phnom Penh: a cross-sectional study.

44. Vaccination status, personal and workplace experiences of early career health professionals in the WiSDOM cohort study during the COVID-19 pandemic in South Africa.

45. A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals.

46. Outpatient rehabilitation in post-acute COVID-19 patients: a combined progressive treatment protocol.

47. Moral values and vaccination behavior in Russia during the COVID-19 pandemic.

48. The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.

49. Multimodal profiling of biostabilized human skin modules reveals a coordinated ecosystem response to injected mRNA-1273 COVID-19 vaccine.

50. Occult COVID-19 in an immunosuppressed patient with migratory pulmonary infiltrates.

Catalog

Books, media, physical & digital resources